Anterogen.Co.Ltd (065660) - Total Liabilities

Latest as of September 2025: ₩1.40 Billion KRW ≈ $951.49K USD

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has total liabilities worth ₩1.40 Billion KRW (≈ $951.49K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 065660 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Anterogen.Co.Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 065660 total asset value.

Anterogen.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Anterogen.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Scully Royalty Ltd NYSE:SRL	USA	$124.67 Million
YHN Acquisition I Limited Unit NASDAQ:YHNAU	USA	$2.35 Million
NPC Resources Bhd KLSE:5047	Malaysia	RM456.29 Million
Sao Ta Foods JSC VN:FMC	Vietnam	₫1.79 Trillion
BIMobject AB ST:BIM	Sweden	Skr110.19 Million
Kumpulan Kitacon Berhad KLSE:5310	Malaysia	RM430.69 Million
Yarrow Bioscience Inc NASDAQ:YARW	USA	$1.24 Million
NEOOTO Co. Ltd KQ:212560	Korea	₩70.52 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Anterogen.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Anterogen.Co.Ltd (065660) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	41.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anterogen.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual total liabilities of Anterogen.Co.Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-70.65%
2023-12-31	₩19.99 Billion ≈ $13.54 Million	+15.25%
2022-12-31	₩17.34 Billion ≈ $11.75 Million	-12.57%
2021-12-31	₩19.83 Billion ≈ $13.44 Million	+50.98%
2020-12-31	₩13.14 Billion ≈ $8.90 Million	-18.91%
2019-12-31	₩16.20 Billion ≈ $10.98 Million	-64.29%
2018-12-31	₩45.37 Billion ≈ $30.75 Million	+293.48%
2017-12-31	₩11.53 Billion ≈ $7.81 Million	+721.17%
2016-12-31	₩1.40 Billion ≈ $951.53K	-24.04%
2015-12-31	₩1.85 Billion ≈ $1.25 Million	+22.79%
2014-12-31	₩1.51 Billion ≈ $1.02 Million	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$81.71 Million

₩120.58 Billion KRW

Market Cap Rank

#20067 Global

#1062 in Korea

Share Price

₩15160.00

Change (1 day)

-0.39%

52-Week Range

₩14840.00 - ₩58000.00

All Time High

₩197700.00